Walleye Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
199,449
+166,243
| +501% | +$1.56M | 0.01% | 649 |
|
|
2025
Q1 | $180K | Buy |
+33,206
| New | +$180K | ﹤0.01% | 1439 |
|
|
2024
Q3 | – | Sell |
-373,974
| Closed | -$3.25M | – | 2592 |
|
|
2024
Q2 | $3.25M | Buy |
373,974
+187,016
| +100% | +$1.63M | 0.01% | 603 |
|
|
2024
Q1 | $3.86M | Buy |
+186,958
| New | +$3.86M | 0.01% | 536 |
|
|
2023
Q2 | – | Sell |
-52,289
| Closed | -$154K | – | 2330 |
|
|
2023
Q1 | $154K | Sell |
52,289
-17,987
| -26% | -$52.9K | ﹤0.01% | 1411 |
|
|
2022
Q4 | $246K | Buy |
+70,276
| New | +$246K | ﹤0.01% | 1272 |
|